Krystal Biotech stock falls nearly 4% despite third quarter earnings beat
Krystal Biotech stock falls nearly 4% despite third quarter earnings beat
Not thousands of headlines. The few lines that move price. For traders: straight from the source, clear and simple.
Krystal Biotech stock falls nearly 4% despite third quarter earnings beat
Both the stock and bond markets are raising doubts about the sustainability of the AI trade.
European gas retreats from 2022 highs following 30% October surge
Take-Two stock rises on strong GTA 6 demand in teen survey
Saudi Arabia’s GDP falls 3.8% in third quarter
Elliptic tracked thousands of transfers, failed swaps and repeated transactions that suggest the hackers relied on scripts rather than AI agents.
Why is Kosmos Energy stock sliding today?
Goldman upgrades BAT on clearer path to sustained revenue growth
Wells Fargo raises Scotts Miracle-Gro price target on margin outlook
Mizuho raises LyondellBasell stock price target on refinery sale
Mizuho raises Amazon stock price target to $335 on AWS outlook
Accused arsonist in Los Angeles’ deadly Palisades fire returns for federal retrial
Morning Bid: Apple’s healthier core
Choice Hotels earnings beat by $0.05, revenue topped estimates
US voters in a sour economic mood heading into midterm elections
Estee Lauder raises annual forecasts on resilient demand ahead of holiday season
IDEXX Labs earnings beat by $0.24, revenue topped estimates
DraftKings stock falls as Susquehanna cites unfavorable October hold
Jefferies sees Airbus stock October deliveries down 17% year-over-year
Bitcoin fell 0.4% to around $77,900 since midnight UTC as Binance customers pulled a net $3.64 billion after withdrawals reopened and ETFs lost $643 million.
News text belongs to its source; only the headline and a short summary appear here.